Insider · CIK 0001675687

Macrae Sandy

Reports to the SEC for 1 company · RICHMOND, CA

sec.gov

Transactions

Companies

Filings

CIK

0001675687

Forms 4 and 5

Insider transactions

49 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-25	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−12.6K sh	$0.17	−$2,198.446	1,895,043
2026-04-01	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director, PRESIDENT, CEO AND DIRECTOR	AAward	+2.5M sh	—	—	2,500,000
2026-02-25	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−33.6K sh	$0.47	−$15.8K	1,907,656
2026-02-24	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−5,291 sh	$0.47	−$2,499.998	1,941,293
2026-01-22	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−103K sh	$0.40	−$41K	1,946,584
2025-11-24	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−7,488 sh	$0.42	−$3,119.501	2,049,534
2025-10-22	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−127K sh	$0.66	−$83.8K	2,057,022
2025-08-24	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−7,488 sh	$0.59	−$4,390.214	2,183,972
2025-07-22	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−127K sh	$0.48	−$60.9K	2,191,460
2025-05-24	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−7,488 sh	$0.47	−$3,544.07	2,318,410
2025-04-22	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−127K sh	$0.78	−$98.6K	2,325,898
2025-02-25	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−10.7K sh	$0.96	−$10.2K	2,077,848
2025-02-25	SGMOQSANGAMO THERAPEUTICS, INCA Award	Director, PRESIDENT, CEO AND DIRECTOR	AAward	+375K sh	—	—	2,452,848
2025-02-25	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director, PRESIDENT, CEO AND DIRECTOR	AAward	+1.75M sh	—	—	1,750,000
2025-02-24	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−7,488 sh	$1.00	−$7,488	2,088,511
2025-01-22	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−413K sh	$1.15	−$474K	2,095,999
2024-11-25	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−10.6K sh	$1.94	−$20.6K	2,508,583
2024-11-24	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−7,473 sh	$1.88	−$14K	2,519,225
2024-08-25	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−7,492 sh	$0.86	−$6,443.12	2,526,698
2024-08-24	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−5,261 sh	$0.86	−$4,524.46	2,534,190
2024-05-25	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−7,492 sh	$0.60	−$4,495.2	2,539,451
2024-05-24	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−5,261 sh	$0.60	−$3,156.6	2,546,943
2024-02-25	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−24.2K sh	$1.13	−$27.3K	2,552,204
2024-02-24	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−16.1K sh	$1.13	−$18.2K	2,576,361
2024-01-22	SGMOQSANGAMO THERAPEUTICS, INCA Award	Director, PRESIDENT, CEO AND DIRECTOR	AAward	+2M sh	—	—	2,592,476
2023-11-25	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−10.4K sh	$0.38	−$3,978.043	592,476
2023-08-25	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−10.4K sh	$0.77	−$8,016.47	602,887
2023-05-25	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−10.4K sh	$1.33	−$13.8K	613,298
2023-02-25	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−54.8K sh	$2.66	−$146K	623,709
2023-02-24	SGMOQSANGAMO THERAPEUTICS, INCA Award	Director, PRESIDENT, CEO AND DIRECTOR	AAward	+157K sh	—	—	678,476
2023-02-24	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director, PRESIDENT, CEO AND DIRECTOR	AAward	+734K sh	—	—	734,050
2022-02-25	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−49.9K sh	$5.90	−$294K	297,176
2022-02-25	SGMOQSANGAMO THERAPEUTICS, INCA Award	Director, PRESIDENT, CEO AND DIRECTOR	AAward	+224K sh	—	—	521,176
2022-02-25	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director, PRESIDENT, CEO AND DIRECTOR	AAward	+605K sh	—	—	604,800
2021-02-25	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−35.3K sh	$11.19	−$395K	208,691
2021-02-25	SGMOQSANGAMO THERAPEUTICS, INCA Award	Director, PRESIDENT, CEO AND DIRECTOR	AAward	+138K sh	—	—	347,066
2021-02-25	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director, PRESIDENT, CEO AND DIRECTOR	AAward	+277K sh	—	—	276,750
2021-01-24	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−3,977 sh	$14.95	−$59.5K	244,002
2020-02-25	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−7,264 sh	$6.80	−$49.4K	79,229
2020-02-25	SGMOQSANGAMO THERAPEUTICS, INCA Award	Director, PRESIDENT, CEO AND DIRECTOR	AAward	+169K sh	—	—	247,979
2020-02-25	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right-to-Buy)A Award	Director, PRESIDENT, CEO AND DIRECTOR	AAward	+338K sh	—	—	337,500
2020-01-24	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−4,283 sh	$7.50	−$32.1K	86,493
2019-02-25	SGMOQSANGAMO THERAPEUTICS, INCA Award	Director, PRESIDENT, CEO AND DIRECTOR	AAward	+63.3K sh	—	—	90,776
2019-02-25	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right-to-Buy)A Award	Director, PRESIDENT, CEO AND DIRECTOR	AAward	+380K sh	—	—	379,500
2018-01-24	SGMOQSANGAMO THERAPEUTICS, INCA Award	Director, PRESIDENT, CEO AND DIRECTOR	AAward	+31.5K sh	—	—	31,500
2018-01-24	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director, PRESIDENT, CEO AND DIRECTOR	AAward	+189K sh	—	—	189,000
2018-01-24	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Director, PRESIDENT, CEO AND DIRECTOR	FTax Payment	−3,974 sh	$11.10	−$44.1K	27,526
2017-01-26	SGMOQSANGAMO THERAPEUTICS, INC · Employee Stock Option (Right to Buy)A Award	Director, PRESIDENT, CEO AND DIRECTOR	AAward	+360K sh	—	—	360,000
2016-06-03	SGMOQSANGAMO THERAPEUTICS, INC · Employee Stock Option (Right to Buy)A Award	Director, PRESIDENT, CEO AND DIRECTOR	AAward	+700K sh	—	—	700,000

Recent filings

Accepted (ET)
May 274
Macrae Sandy0001675687-26-000008
SEC(opens sec.gov)
Apr 34
Macrae Sandy0001675687-26-000006
SEC(opens sec.gov)
Feb 264
Macrae Sandy0001675687-26-000004
SEC(opens sec.gov)
Jan 264
Macrae Sandy0001675687-26-000002
SEC(opens sec.gov)
Nov 264
Macrae Sandy0001675687-25-000008
SEC(opens sec.gov)
Oct 244
Macrae Sandy0001675687-25-000006
SEC(opens sec.gov)
Aug 264
Macrae Sandy0001415889-25-023081
SEC(opens sec.gov)
Jul 244
Macrae Sandy0001415889-25-020245
SEC(opens sec.gov)
May 284
Macrae Sandy0001415889-25-014692
SEC(opens sec.gov)
Apr 244
Macrae Sandy0001415889-25-011283
SEC(opens sec.gov)
Feb 264
Macrae Sandy0001415889-25-005704
SEC(opens sec.gov)
Jan 244
Macrae Sandy0001415889-25-002018
SEC(opens sec.gov)
Nov 264
Macrae Sandy0001415889-24-027702
SEC(opens sec.gov)
Aug 274
Macrae Sandy0001415889-24-022306
SEC(opens sec.gov)

Companies

SANGAMO THERAPEUTICS, INCDirector, PRESIDENT, CEO AND DIRECTORSGMOQ

Address

C/O SANGAMO THERAPEUTICS, INC. 501 CANAL BLVD.

RICHMOND, CA, 94804